(c) 2024 PillSync.com

palbociclib 125 mg

1 INDICATIONS AND USAGE IBRANCE is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with: • an aromatase inhibitor as initial endocrine-based therapy; or • fulvestrant in patients with disease progression following endocrine therapy. IBRANCE is a kinase inhibitor indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with: • an aromatase inhibitor as initial endocrine-based therapy ( 1) ; or • fulvestrant in patients with disease progression following endocrine therapy. ( 1 )

US Pharmaceuticals


2 months ago OVAL PURPLE Pfizer PBC 125 palbociclib 125 mg

OVAL PURPLE Pfizer PBC 125

2 months ago OVAL PURPLE Pfizer PBC 125 palbociclib 125 mg

Pfizer PBC 125 OVAL PURPLE

16 HOW SUPPLIED/STORAGE AND HANDLING IBRANCE is supplied in the following strengths and package configurations: IBRANCE Tablets Package Configuration Tablet Strength (mg) NDC Tablet Description Monthly box containing 3 weekly blister packs of 7 tablets each (21 tablets total) 125 NDC 0069-0688-03 oval, light purple, film-coated tablets debossed with "Pfizer" on one side and "PBC 125" on the other side. Monthly box containing 3 weekly blister packs of 7 tablets each (21 tablets total) 100 NDC 0069-0486-03 oval, green, film-coated tablets debossed with "Pfizer" on one side and "PBC 100" on the other side. Monthly box containing 3 weekly blister packs of 7 tablets each (21 tablets total) 75 NDC 0069-0284-03 round, light purple, film-coated tablets debossed with "Pfizer" on one side and "PBC 75" on the other side. Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature] . Store in the original blister pack.


More pills like OVAL Pfizer PBC 125












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site